NCT00230269View on ClinicalTrials.gov

The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

November 30, 2007

Conditions
Head and Neck Cancer
Interventions
PROCEDURE

PET-CT

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Stanford University

OTHER

NCT00230269 - The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers | Biotech Hunter | Biotech Hunter